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Abstract
Myelin-associated glycoprotein (MAG) is a sialic acid binding Ig-like lectin (Siglec) which has been characterized as potent
myelin-derived inhibitor of neurite outgrowth. Two members of the Nogo-receptor (NgR) family, NgR1 and NgR2, have been
identified as neuronal binding proteins of MAG. In addition, gangliosides have been proposed to bind to and confer the
inhibitory activity of MAG on neurons. In this study, we investigated the individual contribution of NgRs and gangliosides to
MAG-mediated inhibition of sensory neurons derived from dorsal root ganglia (DRG) of ngr1, ngr2 or ngr1/ngr2 deletion
mutants. We found no disinhibition of neurite growth in the absence of either NgR1 or NgR2. Sensory neurons deficient for
both NgR proteins displayed only a moderate reduction of MAG-mediated inhibition of neurite growth. If treated with
Vibrio cholerae neuraminidase (VCN), inhibition by MAG is further attenuated but still not annulled. Thus, disrupting all
known protein and ganglioside receptors for MAG in sensory neurons does not fully abolish its inhibitory activity pointing
to the existence of as yet unidentified receptors for MAG. Moreover, by employing a variety of protein mutants, we
identified the Ig-like domains 4 or 5 of MAG as necessary and sufficient for growth arrest, whereas abolishing MAG’s ability
to bind to sialic acid did not interfere with its inhibitory activity. These findings provide new insights into the inhibitory
function of MAG and suggest similarities but also major differences in MAG inhibition between sensory and central nervous
system (CNS) neurons.
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Introduction
MAG/Siglec-4a is expressed in myelinating glia of the central
and peripheral nervous system (PNS). It is a member of the Siglecs
[1], a sialic acid binding subgroup of the immunoglobulin-
superfamily (IgSF). Membrane-bound MAG contains five extra-
cellular Ig-like domains with the N-terminal V-type Ig-domain
harboring the sialic acid binding site [2,3]. Besides its role in long-
term maintenance of myelin sheaths and axonal integrity [4,5,6],
MAG is known to affect axon growth. Originally described to
support fiber growth of cultured embryonic and early postnatal
neurons [7,8], MAG was later found to impair fiber growth of
mature peripheral and central neurons [9,10]. Two neuronal
proteins of the Nogo-receptor family, NgR1 and NgR2, have been
shown to bind MAG with similar affinity and to confer growth
arrest [11,12,13]. Both receptors are glycosylphosphatidylinositol-
linked proteins and require partner proteins for signal transduc-
tion. NgR1 forms a tripartite receptor complex with the
neurotrophin receptor p75
NTR [14,15] or TROY/TAJ [16,17],
two members of the TNFR superfamily, and the transmembrane
leucin rich repeat protein Lingo-1 [18]. However, recent studies
question whether TROY can serve as a functional substitute for
p75
NTR [19,20]. Membrane spanning constituents of an NgR2
receptor complex have not been identified yet. Besides NgRs,
neuronal gangliosides, notably GT1b and GD1a, seem to directly
interact with MAG via sialic acid residues that are recognized by
MAG’s lectin domain and were proposed to act as independent
functional MAG receptors [21,22,23,24]. Thus far, resolving the
relative contribution of each neuronal MAG receptor constituent
in neurite growth inhibitory signaling has been hampered for two
reasons. First, for lack of genetic deletion mutants, many
experiments on neuronal MAG receptors had to rely on,
sometimes ambiguous, biochemical read-out assays. Second,
MAG and its receptors were studied in different types of neurons.
However, only now is it becoming evident that there are
significant differences in the molecular machinery mediating
MAG inhibition between various neuronal cell types [20,24].
To better understand the function and relative contribution of
NgR1 and NgR2 in MAG-mediated neurite growth inhibition we
analyzed DRG neurons of ngr12/2, ngr22/2 and ngr1/ngr2
double mutant mice in vitro. Sensory neurons are an ideal model
system since they are strongly inhibited by MAG and express all
identified receptor components [13,16,17,25]. We found that only
the combined absence of NgR1/NgR2 and the disruption of
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fully disinhibit sensory neurons. Furthermore, we found that the
inhibitory domains of MAG essential to trigger growth arrest differ
between sensory and CNS neurons. Collectively, our findings
support a model of MAG inhibition that is cell-type specific and
relies on at least three distinct signaling modes.
Materials and Methods
Generation of an ngr2 knock-out mouse strain
For generation of the targeting vector ngr2 genomic sequences
corresponding to intron 1 as well as the 39 untranslated region
(UTR) were amplified and subcloned into the vector pRAY2
(Accession No. U63120). Primers used for amplification of
genomic DNA were (for) 59-TAT AGT CGA CCC TTG GGC
TTT GAC CAT GAT C-39 and (rev) 59-TCT GGG AGC AAC
ACC AGC C-39 for the amplification of the intron 1 homology
region, and (for) 59-TAT AAT CGA TAA GAC CTC AAA GGC
AGC GG-39 and (rev) 59-TAT AGC GGA AGC ACG TGA
TGG GCG TCC CTT GG-39 for the amplification of the 39-
UTR homology region. C57Bl/6 mouse ES cell culture (ES cell
line Bl6-III) [26,27] was performed with primary X-ray-inactivat-
ed embryonic fibroblasts derived from DR4 mice. ES cells were
transfected by electroporation using 12 mg of linearized target
plasmid. Transfected ES cells were selected for neomycin
resistance using 0.2 mg/ml G418 (Invitrogen #10131-019). Ten
days after transfection, G418-resistant ES cell clones were isolated
and analyzed by PCR for homologous recombination. Nested
PCR reactions were carried out using the Qiagen Taq PCR
Master Mix (Qiagen #201445) with the first primer pair: Neo-
fw1: 59-CTT GCC GAA TAT CAT GGT GG-39; NgRH1-rev1:
59-TGG CTG GTG TGC TTA CAC TT-39 and the second
primer pair: Neo-5: 59-CAG GAC ATA GCG TTG GCT AC-39;
NgRH1-F1: 59-CTG AGG TGC ATC TGC CTG TT-39.A
targeting frequency of 6.25% was observed yielding a total of five
targeted ES cell clones. Homologous recombination was con-
firmed by Southern Blot analysis. Ten micrograms of genomic
DNA were digested with 50 units of RsrII and separated on a
0.9% agarose gel. After denaturation the DNA was blotted onto a
Hybond N+ membrane (GE Healthcare #RPN203B) followed by
UV crosslinking. An NgR2 DNA probe was amplified by PCR
using primers NgRH1-SpFw: 59-AGG CTC AGG TTC TGT
TGT CC-39 and NgRH1-SpRv: 59-GCT GCC AGA CCT TGG
AGT AC-39. Hybridization with the
32P-labeled DNA probe
(Rediprime II Random prime labeling kit; GE Healthcare
#RPN1633) was performed in Perfect Plus Hybridization buffer
(Sigma-Aldrich #H7033) at 65uC overnight. After washing the
hybridized membrane, image analysis was performed using a Fuji
FLA-5000. Following karyotype analysis ES cells of three targeted
clones were injected into Balb/c host blastocysts, which were
subsequently transferred into pseudopregnant CB6F1 foster
mothers. Chimeric offspring were identified by coat pigmentation
(black C57Bl/6 on a white Balb/c background). Black offspring
indicated the germline transmission of the targeted ES cells.
Genotyping of targeted mice was done via PCR assaying for
deletion of exons 2 and 3. Using genomic DNA obtained from tail
biopsies two separate PCR reactions were applied in order to
discriminate between heterozygous, homozygous and wildtype (wt)
mice. PCR primer to detect the wt allele: NgRH1: 59-TTG TCT
GCA GAG CAC CTT CCA C-39; NgRH1 rev: 59-TTC TCT
GTG TAA CAG CCT TGG G-39. A 500 bp amplification
product is expected. PCR primer to detect the targeted allele: Neo
starts: 59-ATG GGA TCG GCC ATT GAA CAA-39; NgRH1
rev: 59-TTC TCT GTG TAA CAG CCT TGG G-39. A 1.1 kb
amplification product is expected. The absence of an NgR2
transcript in brain tissue from homozygous null mice was tested
with real-time and reverse transcription PCR. To this end, total
RNA was isolated from mouse brain using Tripure Isolation
Reagent (Roche #1 667 165) followed by DNaseI treatment.
Reverse transcription of RNA was performed with Omniscript RT
Kit (Qiagen #205111). PCR was carried out with Taq-polymerase
(Roche #1 146 173) and NgR2 specific primers (NgR2for: 59-
TGA CTT GTT CGC GGA CCT GG-39; NgR2rev: 59-GAG
GAT GGT GAG GCG GCT GA-39) yielding a product of
181 bp. Real-time PCR was done with a Light Cycler (Roche)
using Quantitect SYBRH Green PCR Kit (Qiagen #204143).
NgR2 signals were normalized to GAPDH mRNA. The ngr2
knock-out mouse line was named Bl6-TgH(NgRH1)
143Npa,
according to the guidelines of the International Committee on
Standardized Genetic Nomenclature for Mice.
The ngr12/2 mice are described elsewhere [27]. The absence
of NgR1 in knock-out animals was verified by PCR-genotyping of
tail biopsies using the following primers: NR3F1: 59-TCG GCA
CAT CAA TGA CTC TCC-39, NR3R3: 59-TAT GTA CAC
ACA CCT GGT GGC-39 and bpA2: 59-TGG GCT CTA TGG
CTT CTG AG-39. A 325 bp amplicon is expected for the
wildtype allele and a 210 bp amplicon for the targeted allele.
DNA constructs
MAGp72_pXM plasmid containing full-length rat L-MAG was
a kind gift from Rainer Hillenbrand, Basel, Novartis Institutes for
BioMedical Research [28], MOG_pCMV containing full-length
human MOG alpha variant was provided by Markus Reindl,
Innsbruck Medical University and N-CAM_pBK-CMV contain-
ing full-length chicken N-CAM180 was given to us from Jozsef
Kiss, Geneva, University Medical Center. The coding sequence of
MAG was subcloned in the pKS+ vector using KpnI and BamHI
for further cloning steps (MAG_pKS+). The MAG mutant R118A
was generated by site-directed mutagenesis using the ‘‘Quik-
Change
TM site-directed mutagenesis kit’’ of Stratagene (#200519)
and MAG_pKS+ as template. The primer sequence was: 59-GGA
GGG AAA TAC TAT TTC GCA GGT GAC CTG GGC GG-39
and 59-CC GCC CAG GTC ACC TGC GAA ATA GTA TTT
CCC TCC-39, changing the original Arg
118 codon ‘‘CGA’’ to Ala
codon ‘‘GCA’’. The mutation was confirmed by sequencing.
MAG Ig1–3 was generated by PCR using MAG_pKS+ as
template and primers sparing the sequence encoding Ig-like
domains 4 and 5 (for: 59-TAA CCC GGG CTG ATG TGG GCC
AAA ATC GGC-39; rev: 59- TCC AAC CCG GGT GCA TAC
ATG ACG CTG TCG-39). The MAG replacement mutants rIg4
and rIg5 were constructed from MAG_pKS+ and N-CAM_pBK-
CMV plasmid. MAG sequence lacking Ig-like domain 4 or 5 was
PCR-amplified using MAG_pKS+ as template and primers
containing linkers for HindIII and KasI. The primer sequences
were: rIg4 (for: 59-ATT GGC GCC CCC ATA ATC CTT CTG
GAA TCG CAC-39; rev: 59-CCC CAA GCT TAG GTG CAT
ACA TGA CGC TCA GC-39; linkers marked) and rIg5 (for: 59-
ATC GGC GCC CTG ATG TGG GCC AAA ATC-39; rev: 59-
CCC CAA GCT TAG CAA ACT CCA CAG ACA GG-39;
linkers marked). The sequence encoding the Ig4 domain of N-
CAM was PCR-amplified using N-CAM_pBK-CMV as template
and primers containing linkers for HindIII and KasI (for: 59-CCC
AAG CTT GAG GAT CAG ATC ACA CTG ACC-39; rev: 59-
ATC GGC GCC GAT GGT GTT GCT GGC C-39; linkers
marked). The N-CAM Ig4 amplicon was inserted into the MAG
amplicon lacking the sequence for either Ig-like domain 4 or 5.
The chimeric cDNAs were finally cloned into the expression
vector pBK-CMV (Stratagene #212209) using KpnI and BamHI
MAG Acts in Absence of NgRs
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5218sites. For generation of chimeric MOG/MAG constructs, the
sequence encoding MAG Ig-like domains 4, 5 and 4/5 was PCR-
amplified using MAG_pKS+ as template and primers containing
StuI and KasI linkers (for Ig4: 59-AGG CCT TGG AAG CCC
ACA GTG AAT-39; rev Ig4: 59-GGC GCC GGG AGC AAA
CGC CA-39; for Ig5: 59-AGG CCT ATA ATC CTT CTG GAA
TCG CAC-39; rev Ig5: 59-GGC GCC TCG GTG TGC TCC-39;
linkers marked). Amplicons were cloned into MOG_pKS+ cut
with StuI and KasI thus inserting the MAG domains between
Arg
130 and Asp
131 of MOG. Chimeric MOG/N-CAM was
generated by PCR-amplifying the sequence encoding the Ig4
domain of N-CAM using N-CAM_pBK-CMV as template and
primers with StuI and KasI linkers (for: 59-CCT AGG CCT GAG
GAT CAG ATC ACA CTG ACC-39; rev: 59-ATC GGC GCC
GAT GGT GTT GCT GGC C-39; linkers marked) and inserting
the amplicon into MOG_pKS+ cut with StuI and KasI. The
MOG/MAG and MOG/N-CAM constructs without the signal
peptide were subcloned in a modified pAPtag-5 vector (GenHun-
ter #Q202) containing an N-terminal V5-tag.
CHO-K1 cell lines
CHO-K1 cells were grown as described previously [29]. To
generate CHO-K1 clones stably expressing wildtype or mutant
MAG, cells were transfected with respective constructs using
Lipofectamine 2000 (Invitrogen #11668-019) and selected with
1 mg/ml G418 (pBK-CMV-constructs; Invitrogen #11811-031)
or 200 mg/ml zeocin (pAPtag-5-constructs; Invitrogen #45-043).
Transfected cells were subjected two to three times to fluores-
cence-activated cell sorting (FACS) using the monoclonal anti-
MAG 513 antibody (Millipore #MAB1567) for MAG R118A,
MAG Ig1–3, MAG rIg4 and MAG rIg5, the monoclonal anti-V5
antibody (Invitrogen #R960-25) for the MOG/MAG and MOG/
N-CAM chimeric proteins and the monoclonal anti-MOG (clone
8.15-C5; kind gift from Markus Reindl, Innsbruck Medical
University) for MOG transfected cells. Clonal cell lines were
obtained by limiting dilution of the sorted cell populations.
Aliquots of a dilution containing in theory 1 cell/100 ml were
seeded in a 96-well plate. Screening for positive clones was done
with live cell surface immunofluorescent staining. Clones with
highest expression level were chosen for neurite outgrowth assays.
Immunocytochemistry
For live-staining CHO cells expressing MAG or MAG-mutants
were seeded onto glass cover slips. After overnight culture they were
washed once with PBS and incubated with 10 mg/ml anti-MAG
513 antibody or 1 mg/ml anti-V5 antibody or 2.5 mg/ml anti-
MOG (clone 8.15-C5) for 25 min at room temperature. Following
fixation with 4% (w/v) paraformaldehyde and 5% (w/v) sucrose in
PBS cells were incubated for one hour at room temperature with a
Rhodamine-labeled goat anti-mouse IgG (1:700; Millipore
#AP124R). The coverslips were mounted (Fluorescence mounting
medium; Dako #S3023) and pictures were taken with a Zeiss
Axioplan2 microscope equipped with a spot camera (RT-Slider
2.3.1, Visitron Systems, Puchheim, Germany).
Sensory neurons
Preparation of sensory neurons from DRG was described
previously [30]. Briefly, ganglia were obtained from P7-P9
wildtype or transgenic mice. Ganglia were digested two times,
30 min each, at 37uC with 0.09 mg/ml liberase blendzyme 1
(Roche #11 988 409 001) in DMEM, washed twice with PBS and
incubated for another 30 min with 0.05% (w/v) trypsin (Invitro-
gen #15090). After trituration cells were spun through DMEM/
3.5% (w/v) BSA and resuspended in complete medium [31].
Sensory neurons were plated in complete medium onto monolay-
ers of CHO-K1 cells.
Neurite outgrowth assay and statistical analysis
Neurite outgrowth assays on confluent monolayers of parental
CHO-K1 cells or CHO cells overexpressing wildtype MAG,
mutant MAG, MOG/MAG or MOG/N-CAM chimeras was
performedasdescribed previously[32].Briefly,approximately6000
sensory neurons were added to the CHO-K1 monolayers in
complete medium. Where indicated Vibrio cholerae neuraminidase
(VCN; Sigma-Aldrich #N7885) was added at the indicated
concentration one hour after plating the neurons. Specificity of
VCN treatment was revealed as described in Method S1. Following
anincubation periodofapproximately20 hourscellswerefixedand
neurons were stained for better visualization with anti-GAP43 as
described [32]. The coverslips were mounted and fluorescent
pictures from isolated neurons were taken in a systematic manner
with a Zeiss Axioplan2 microscope equipped with a spot camera
(RT-Slider 2.3.1, Visitron Systems, Puchheim, Germany). Neurite
length was determined by measuring the maximal distance from the
center of the cell body to the furthest neurite from digitized images
of approximately 50 individual neurons per experiment and
condition using MetaVue 5.0r3 software (Universal Imaging
Corporation, PA, USA). The mean and SEM of neurite-bearing
cells were calculated from at least three to seven independent
experiments.Data wereanalyzed by one-way ANOVA, followed by
Tukey post hoc analysis with SPSS 15.0.1 2006 for Windows (SPSS,
IL, USA). Error bars indicate SEM.
Western Blotting
Cells were lysed in 50 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.1% (w/v) SDS, 1% (v/v) NP40, 10 mg/ml aprotinin, 5 mg/ml
leupeptin, 1 mg/ml pepstatin and 174 mg/ml phenylmethylsulfonyl
fluoride (PMSF). Lysates were sonicated for 10 sec and centrifuged
for 15 min at 4uC at 21.0006g. Protein concentration was
determined using BioRad Protein Assay (#500-0006), b-mercapto-
ethanol was added and lysates were incubated at 95uCf o r5m i n
before they were subjected to SDS-PAGE. Proteins were transferred
onto polyvinylidene difluoride membrane (Millipore, Immobilon-P,
#IPVH00010) and blocking was carried out with 3% (w/v) gelatine
(hydrolysed gelatine #17079/1; Naumann – Gelatine und Leim
GmbH,Memmingen,Germany)inTBS/0.1%(v/v)Tween-20 for1
hour. Proteins were detected with antibodies as indicated: 0.2 mg/ml
polyclonalgoatanti-MAG(L-20;SantaCruz#sc-9543),0.25 mg/ml
monoclonal mouse anti-MOG (clone 8.15-C5), 0.107 mg/ml
monoclonal mouse anti-V5 (Invitrogen #R960-25), 0.29 mg/ml
polyclonal goat anti-Flotillin-1 (K-19; Santa Cruz #sc-16640),
0.1 mg/ml monoclonal mouse anti-a-Tubulin (DM1A; Sigma-
Aldrich #T 9026) overnight at 4uC in 1.5% (w/v) gelatine in
TBS/0.1% (v/v) Tween-20. After three washes with TBS/0.1% (v/
v) Tween-20, membranes were incubated with the HRP-conjugated
secondary antibodies rabbit anti-goat IgG (1:14.000; Pierce #31402)
or goat anti-mouse IgG (1:20.000; Pierce #31432) for one hour at
room temperature in 1.5% (w/v) gelatine in TBS/0.1 % (v/v)
Tween-20. After three washing steps HRP activity was detected with
ECL-Plus Western blotting detection reagent (GE Healthcare
#RPN 2132) using a Typhoon 9410 scanner (GE Healthcare).
Glycosylation patterns were revealed as described in Method S2.
Results
Generation of ngr mutant mouse strains
Inactivation of the murine ngr2 gene was achieved by targeted
disruption of exons 2 to 3 with a strategy depicted in Figure 1A.
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coding sequence was deleted and the mutation was therefore
expected to be a null allele. The targeted allele was obtained in
C57Bl/6 ES cells (B16-III cell line; [26]) as confirmed by Southern
Blotting of ES cell genomic DNA (Fig. 1B). ES cells of three
targeted clones were injected into Balb/c host blastocysts and
germline transmission was achieved with one clone. Real-time and
reverse transcription PCR with brain cDNA of homozygous null
Figure 1. Generation of ngr2 deletion mutant mice. (A) Targeting strategy for the ngr2 mutant. Genomic sequences in intron 1 and 39UTR of
the ngr2 gene were used as targeting sites. (B) Southern analysis of ES cell clones; the expected signal for a targeted clone is at 6.2 kb. Germline
transmission after blastocyst injection was obtained for ES cell clone 9H (circled). (C) Real-time-PCR (left) and reverse transcription PCR (right) for NgR2
with mouse brain cDNA confirm the absence of NgR2 in 2/2 animals. (D) Genotyping of mice using genomic DNA from tail biopsies of wt, ngr12/2,
ngr22/2 and ngr1/22/2 animals. HSVtk, Herpes simplex virus thymidine kinase gene; neo, neomycin resistance gene; polyA, polyadenylation site.
doi:10.1371/journal.pone.0005218.g001
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genomic level, the mutant allele was detected by PCR-based
genotyping of tail biopsies (Fig. 1D). Expression of NgR1 or other
known receptor components conferring MAG responsiveness such
as p75
NTR or TROY/TAJ were unaltered in cultured sensory
neurons (data not shown). Heterozygous ngr2 mice appeared
phenotypically normal and fertile, and intercrosses between
heterozygous mice yielded homozygous ngr2 knock-out animals
at a normal Mendelian frequency. Similar to ngr1 deletion mutants
[27], homozygous adult ngr2 null mice appeared healthy, and
histological examination showed no obvious abnormalities in the
brain, liver or heart (not shown). ngr1/2 double null mice were
generated by cross-breeding ngr1 and ngr2 deletion mutants and
the absence of both the ngr1 and ngr2 wildtype allele was
demonstrated by PCR-based genotyping of tail biopsies (Fig. 1D).
ngr1/2 double null mice are viable and fertile and morphologically
indistinguishable from wildtype animals.
Absence of NgR1 or NgR2 alone does not attenuate MAG
inhibition of sensory neurons
Previous studies showed that MAG transduces its repulsive
signals by binding to NgR1 [11,12] or NgR2 [13]. Because both
receptors are abundantly expressed on DRG neurons [13,25] we
were interested to study their relative contribution to MAG
inhibition in a mouse genetic approach. In order to present MAG
to neurons in a physiological manner, we used a CHO-K1 cell line
that expressed significant levels of MAG on the cell surface as
revealed by live-staining (Fig. 2A) and tested its ability to modulate
neurite outgrowth of postnatal sensory neurons from mice
deficient for NgR1 or NgR2. As reported previously [10], sensory
neurons grown on a CHO-MAG substrate have shorter and less
branched neurites compared with those grown on a CHO control
substrate (Fig. 2B). Quantitative analysis revealed that neurite
length of wildtype murine sensory neurons is significantly reduced
by approximately 40% on CHO-MAG cells compared to parental
CHO-K1 cells (Fig. 2B,C). In agreement with recent reports
[27,33] we found no difference in MAG inhibition between
wildtype neurons and ngr1 null neurons (Fig. 2B,C). Likewise,
neurite extension of sensory neurons from ngr22/2 mice was as
potently inhibited as that of wildtype or ngr12/2 animals
(Fig. 2B,C). Thus, sensory neurons of wildtype and ngr mutant
genotype were indistinguishable in neurite extension on control
CHO cells and equally inhibited on CHO-MAG cells (Fig. 2C).
Together these observations imply that deletion of NgR1 or
NgR2 alone is not sufficient to render sensory neurons insensitive
to MAG inhibition.
Additive, but incomplete, attenuation of MAG inhibition
upon combined deletion of NgR1 and NgR2 and
neuraminidase treatment
Given the high degree of homology between NgR1 and NgR2
we hypothesized that the lack of a robust phenotype in the neurite
outgrowth response to MAG from neurons deficient for either
NgR1 or NgR2 was attributed to functional redundancy between
the two receptor constituents. To test this hypothesis, we analysed
sensory neurons from ngr1/ngr2 double knock-out mice for their
MAG responsiveness. Surprisingly, in comparison to wildtype or
single mutant neurons, combined deletion of NgR1 and NgR2
resulted in only a moderate, albeit significant, release of inhibition
of approximately 33% (Fig. 3). No difference was observed
between wildtype and double null neurons on control CHO cell
substrate. This result demonstrates a partial functional redundancy
between NgR1 and NgR2 in sensory neurons with regard to
inhibitory MAG signaling, and implies that additional neuronal
constituents account for the residual response.
Because recent findings suggest that gangliosides, notably GT1b
and GD1a, can act as functional MAG receptors on neurons in a
sialic acid dependent manner [21,22,23,24], we examined whether
disrupting gangliosides on ngr1/ngr2 double null neurons would
result in full release of MAG inhibition. For this purpose we
cultured wildtype and mutant sensory neurons in the presence of
different concentrations of vibrio cholerae neuraminidase (VCN).
This enzyme removes terminal sialic acid residues from sialylated
cell surface molecules including gangliosides and was shown to
render sensory neurons less responsive to MAG [24]. In control
experiments we demonstrated the effectiveness and specificity of
VCN in our neuronal cell culture by showing that VCN treatment
caused an increase in the level of membrane monosialylated GM1
as determined by cholera toxin binding (Fig. S1). To our surprise,
in the presence of 5 mU/ml of VCN MAG inhibition of double
null sensory neurons was attenuated from 73% (untreated) to only
86% (VCN-treated) (Fig. 3). Also at higher VCN concentrations
the inhibitory response could not be further reduced (data not
shown), indicating that the VCN concentration was at saturation.
Thus, the combined absence of NgR1, NgR2 and sialic acid
bearing gangliosides diminished MAG inhibition of sensory
neurons by only 65%. Consistent with a previous study using
wildtype rat retinal ganglion cells [20], we found that the presence
of VCN did not result in a significant MAG disinhibition of
wildtype sensory neurons (Fig. 3), presumably due to functional
compensation by the NgR receptors.
Together, these results indicate that both NgR proteins and
gangliosides are involved in MAG inhibition, but are not the only
molecules to trigger MAG-mediated growth arrest of sensory
neurons.
Construction and functional analysis of MAG deletion
and replacement mutants
Given significant differences in the configuration of the MAG
receptor complex between sensory neurons and cerebellar granule
cells [20,24] we next asked whether cell-type specific differences of
MAG inhibition exist also at the ligand level. Previous reports by
Filbin’s lab suggested that the neurite inhibitory domain on MAG
resides within the Ig-like domains 4 to 5 since mutant MAG
comprising Ig1–3 (MAG Ig1–3) does not inhibit neurite outgrowth
[3]. More recently, the inhibitory site on MAG was mapped to Ig-
like domain 5 for cerebellar granule neurons (CGN) [34]. To test if
the same or other domains are responsible for mediating MAG’s
growth inhibiting activity for murine DRG neurons, we created
several deletion and chimeric mutants as shown in Fig 4A. To
determine whether the deletion and chimeric proteins were
expressed in cells and translocated to the cell surface we produced
CHO cell lines expressing these mutant MAG constructs. Live
stainings of the transfected cell lines as is shown in Fig. 4C revealed
that all mutant proteins were expressed on the cell surface of CHO
cells, suggesting that none of these proteins was impaired in
expression, overall folding or translocation to the cell surface.
Independent stable lines were obtained following FACS and serial
subcloning. Clones expressing near-equivalent amounts of full-
length and mutant forms of MAG (Fig. 4B) were used for neurite
outgrowth experiments described below.
MAG Ig4 or Ig5 is necessary for inhibition of sensory
neurons
Quantification of neurite outgrowth of wildtype sensory neurons
on CHO-MAG Ig1–3 cells revealed that neurite elongation is not
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grown on CHO control cells. This finding is in agreement with an
identical approach using CGN [34] and suggests that the
inhibitory region of MAG for sensory neurons lies within the Ig-
like domains 4 and/or 5. To examine which of the two Ig domains
is responsible for mediating the growth inhibiting activity, we
replaced MAG Ig4 or Ig5 by the Ig4 domain of the chicken N-
CAM molecule, a related molecule that lacks inhibitory activity.
Although the N-CAM Ig4 domain is slightly smaller than the
MAG Ig domains (74 aa versus 86 aa for Ig4 and 96 aa for Ig5),
the resulting chimeras MAG rIg4 and MAG rIg5 retained the
domain organization of the parental MAG molecule.
As observed with CGN [34], neurite length of DRG neurons
was found to be equally inhibited on CHO-MAG rIg4 as on
wildtype MAG (Fig. 4D). To our surprise, however, sensory
neurons were also fully inhibited on CHO-MAG rIg5 (Fig. 4D),
despite the fact that MAG rIg5 expression was lower in
comparison to wildtype MAG or MAG rIg4 (Fig. 4B). This result
clearly demonstrates a redundancy between the Ig-like domains 4
and 5. If both are deleted the inhibitory activity of MAG is
abolished, but the presence of either domain 4 or 5 is sufficient to
confer full inhibition. These findings add significantly to the
concept of cell-type specific mechanisms of MAG inhibition, in
particular when comparing sensory and cerebellar granule
neurons.
Introduction of MAG Ig4 or Ig5 is sufficient to convert a
non-inhibitory molecule into a neurite outgrowth
inhibitor
To test whether the Ig4 and/or Ig5 domains of MAG are
sufficient to inhibit neurite growth as single domains, we created a
second set of chimeras, where Ig4 and/or Ig5 were fused to the Ig
domain of MOG (myelin oligodendrocyte glycoprotein; Fig. 5A).
MOG is a CNS myelin specific cell-adhesion molecule with no
inhibitory activity on postnatal DRG (Fig. 5D). We placed Ig-like
domains 4, 5 and 4/5 of MAG between the transmembrane
domain and Ig-V of MOG giving rise to chimeric MOG-MAG
proteins MOG-MAG Ig4, MOG-MAG Ig5 and MOG-MAG
Ig4–5, respectively (Fig. 5A). CHO cells transfected with the
various constructs expressed the chimeric molecules on the cell
surface (Fig. 5C) and clonal cell lines expressing comparable levels
of wildtype MAG and chimeras (Fig. 5B) were used for neurite
growth analysis. Results of neurite outgrowth assays obtained with
these gain-of-function constructs are shown in Fig. 5D. While
growth of sensory neurons was not impaired on MOG, we found
that MOG-MAG Ig4 and MOG-MAG Ig4/5 achieved virtually
the same inhibitory activity as full-length MAG (Fig. 5D). Neurite
growth was significantly, albeit slightly less inhibited on MOG-
MAG Ig5 (Fig. 5D), suggesting that the Ig-like domain 5 of MAG
has somewhat weaker inhibitory potential than the Ig-like domain
4, at least in the structural context of the MOG molecule.
Figure 3. MAG-mediated inhibition of neurite outgrowth of ngr1/22/2 sensory neurons with and without VCN treatment. Sensory
neurons derived from wildtype or ngr1/22/2 mice were seeded onto parental and MAG expressing CHO-K1 cells. Treatment with 5 mU/ml Vibrio
cholerae neuraminidase (VCN) was started one hour after plating. Cells were fixed approx. 20 hours after plating. Graph shows % neurite length6SEM
of wildtype and ngr1/ngr2 double knock-out neurons on the different substrates. At least three separate experiments were examined for each
experimental condition, with 100–150 neurons measured for each substrate. *** represents P#0.001, ** represents P#0.01 one-way analysis of
variance with post-hoc Tukey test.
doi:10.1371/journal.pone.0005218.g003
Figure 2. MAG-mediated inhibition of neurite outgrowth of ngr12/2 and ngr22/2 sensory neurons. (A) A clonal CHO-K1 cell line stably
expressing MAG was raised and characterized. Live anti-MAG immunostaining (parental CHO-K1 versus MAG overexpressing clone) demonstrated
surface expression of MAG. Scale bar 20 mm. (B) Photomicrographs show GAP-43-positive DRG neurons from wildtype, ngr12/2 and ngr22/2 mice
after a culture period of 20 hours on CHO control or CHO-MAG substrates. Neurite extension of all genotypes is markedly reduced on MAG
expressing CHO-K1 cells. Scale bar 40 mm. (C) Quantification of neurite length of DRG neurons from wildtype, ngr12/2,o rngr22/2 mice grown on
MAG-expressing CHO cells. CHO-K1 cells served as the control substrate. Graph shows % neurite length on the different substrates6SEM. At least five
separate experiments were examined for each experimental condition, with 100–150 neurons measured for each substrate. *** represents P#0.001
compared to CHO-K1, one-way analysis of variance with post-hoc Tukey test.
doi:10.1371/journal.pone.0005218.g002
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PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5218Figure 4. Inhibition of neurite outgrowth by MAG mutants lacking the Ig-like domains 4 and/or 5. (A) Domain composition of the full-
length MAG protein and chimeric proteins used to transfect CHO cells in this study. Specific regions within the MAG ectodomain were either deleted
(MAG Ig1–3) or replaced by the N-CAM Ig4 domain (dashed line). (B) Western Blot analysis of clonal cell lines expressing MAG mutants (arrow points
to not fully glycosylated form; see Fig. S2). Ten micrograms of total protein lysate were loaded in each lane. Goat anti-MAG antibody was used to
detect MAG; to reveal equal protein load, blots were incubated with anti-flotillin antibody. (C) Cell surface expression of full-length MAG and chimeric
MAG proteins by transfected CHO cells after FACS and clonal selection as revealed by live-staining with anti-MAG antibody. Scale bar 20 mm. (D)
Analysis of neurite length of wildtype DRG neurons grown on CHO cell monolayers expressing full-length or chimeric forms of MAG. Parental CHO
cells served as the control substrate. Graph shows % neurite length on the different substrates6SEM. Three to seven separate experiments were
examined for each experimental condition, with 50 to 100 neurons measured for each substrate. *** represents P#0.001 compared to CHO-K1,
**p#0.01, *p#0.05 one-way analysis of variance with post-hoc Tukey test.
doi:10.1371/journal.pone.0005218.g004
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single Ig domain is sufficient to convey inhibition, we wanted to
exclude that these effects are induced by the altered structure of
the MOG protein backbone. As control, we constructed a MOG-
N-CAM chimera, MOG-N-CAM Ig4, with the Ig4 domain of
chicken N-CAM inserted into MOG (Fig. 5A). Chimeric MOG-
N-CAM Ig4 failed to inhibit neurite outgrowth suggesting that the
observed effects were not due to a possible conformational change
of MOG protein (Fig. 5D). In essence, these data fully confirm our
findings obtained with the MAG replacement mutants.
Taken together, for sensory neurons the inhibitory region of
MAG seems to cover the Ig-like domains 4 and 5; either domain -
Figure 5. Inhibition of neurite outgrowth by chimeric MOG-MAG molecules. (A) MOG-MAG chimeras, in which either one or two domains of
MAG (grey lines) were fused to the MOG Ig-V domain. MOG-N-CAM Ig4 indicates the fusion of the Ig4 domain of the N-CAM molecule to the MOG Ig-
V domain. All chimeric proteins have a signal peptide (SP) and carry the cytoplasmic part of MOG along with a V5-tag at their N-terminus. Stable CHO-
K1 clones expressing either of these chimeras were generated and characterized by (B) Western Blotting and (C) live anti-V5 immunostaining
demonstrating surface expression of each chimera. Scale bar 20 mm. Respective analysis of a MOG expressing CHO-K1 clone was done using an anti-
MOG antibody. a-tubulin served as loading control for Western Blots. (D) Analysis of neurite length of wildtype DRG neurons grown on CHO cell
monolayers expressing full-length or chimeric forms of MAG. Parental CHO cells served as the control substrate. Graph shows % neurite length on the
different substrates6SEM. Three to seven separate experiments were examined for each experimental condition, with 50 to 100 neurons measured
for each substrate. *** represents P#0.001 compared to CHO-K1, **p#0.01, *p#0.05 one-way analysis of variance with post-hoc Tukey test.
doi:10.1371/journal.pone.0005218.g005
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on neurite outgrowth. This finding is in marked contrast to
cerebellar granule neurons which are inhibited by MAG’s Ig-like
domain 5, but not 4 [34], and demonstrates that cell-type specific
mechanisms of MAG inhibition exist not only at the receptor, but
also at the ligand level.
Removal of the sialic acid binding site does not attenuate
MAG inhibition
A characteristic feature of MAG is its sugar binding ability and
it was investigated early on whether the lectin activity of MAG is
related to its inhibitory effect on neurons. Previous studies showed
that Arg
118 in Ig domain 1 is crucial for sialic acid binding of
MAG [3], but that the sialic acid binding ability of MAG is not
necessary for inhibition [3]. The latter experiments were carried
out with CGN and we wondered whether sialic acid binding of
MAG is of any significance for conferring inhibitory activity on
sensory neurons. By site-directed mutagenesis we constructed a
MAG mutant that had Arg
118 replaced with Ala, termed MAG
R118A (Fig. 6A). A CHO clone that stably expressed MAG
R118A on the cell surface (Fig. 6B, C) was used as a substrate for
sensory neurons. No difference in the neurons’ responsiveness to
the MAG mutant in comparison to wildtype MAG was observed
neither with wildtype nor ngr1/ngr2 double knock-out neurons
(Fig. 6D), confirming that the sialic acid binding ability of MAG is
not necessary for its inhibitory activity on neurons.
Discussion
In the present study we investigated the distinct contribution of
the known protein and lipid-type MAG receptors to neurite
outgrowth inhibition in DRG derived sensory neurons. Using a
direct mouse genetic approach we found that neither NgR1 nor
NgR2 play a prominent role in transducing MAG’s inhibitory
growth effects. Likewise, removal of cell surface terminal sialic
Figure 6. Inhibition of neurite outgrowth by a MAG mutant lacking the sialic acid binding site. (A) The name MAG R118A refers to a
point-mutation within the sialic-acid binding domain of MAG (asterisk), that abolishes MAG binding to specific gangliosides. (B) Western Blot analysis
of a CHO clone stably expressing MAG R118A. Ten micrograms of total protein lysate were loaded for each lane. Goat anti-MAG antibody was used to
detect MAG; to reveal equal protein load, blots were incubated with anti-flotillin antibody. (C) Cell surface expression of full-length MAG and MAG
R118A proteins by transfected CHO cells after FACS and clonal selection as revealed by live-staining with anti-MAG antibody. Scale bar 20 mm. (D)
Analysis of neurite length of wildtype and ngr1/ngr2 double knock-out DRG neurons grown on CHO cell monolayers expressing full-length MAG or
MAG R118A. Parental CHO cells served as the control substrate. Graph shows % neurite length on the different substrates6SEM. Three separate
experiments were examined for each experimental condition, with 50 to 100 neurons measured for each substrate. *** represents P#0.001 compared
to CHO-K1, one-way analysis of variance with post-hoc Tukey test.
doi:10.1371/journal.pone.0005218.g006
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the combined loss of NgRs and terminal sialic acids was not
sufficient to fully overcome MAG inhibition. Based on these
observations we suggest that MAG can signal via other, yet
unidentified receptor molecules. In addition, we provide evidence
that cell-type specific differences of MAG inhibition exist not only
at receptor level, as suggested by previous studies, but also at
ligand level.
MAG is one of the best characterized myelin-associated proteins
found in both the PNS and CNS [35]. Prior studies demonstrated
that MAG not only contributes to the long-term maintenance of
axon-myelin integrity [4,5,6], but impairs axon growth. MAG
effectively restricts neurite outgrowth of late postnatal neurons in
vitro [9,10] and appears to inhibit fiber regeneration in the injured
peripheral [36] and central [37] adult nervous system in vivo.
Characterizing the neuronal receptor complex that mediates
inhibitory MAG signaling revealed that MAG binds independent-
ly to different receptors, including NgR1 [11,12,13] and NgR2
[13], two GPI-anchored receptor proteins, as well as to GT1b and
GD1a [21,22], two major neuronal gangliosides (sialylation was
shown to be mandatory for MAG binding). Based on biochemical
and immunological experiments, all four interactions were
proposed to be relevant for MAG inhibition, but the relative
contribution of each interaction remained elusive. The functional
significance of NgR1 has recently been challenged, since the
absence of NgR1 on sensory neurons or cerebellar granule cells
did not lead to disinhibition of neurite growth on preparations of
total myelin [27] or on MAG presenting CHO-K1 cells [20,33].
Since MAG binds with similar affinity to the structurally related
NgR2 protein [13], the role of NgR1 might have been
compensated partly by that of NgR2 in ngr1 knock-out mice.
Alternatively, the selective interaction of MAG with gangliosides
could compensate for the loss of NgR1. Hence, the generation of
ngr2 and ngr1/2 deletion mutant mice provides unique animal
models that permit investigation into the relative contribution of
these receptors in MAG-dependent neurite growth inhibition. As
prior studies noted for NgR1 [20,33], absence of NgR2 alone was
not sufficient to release sensory neurons from MAG inhibition.
Also the enzymatic removal of terminal sialic acids did not
disinhibit sensory neurons as was reported recently for rat retinal
ganglion cells [20]. If NgR1 and NgR2 are functionally redundant,
neurons of ngr1/2 double knock-out mice would be expected to be
significantly less inhibited by MAG. However, inhibition of
sensory neurons was only moderately released, suggesting that
NgR proteins play only a minor role as functional inhibitory MAG
receptors. We hypothesized that compensation at the level of
gangliosides might account for these unexpected findings because
MAG independently binds to the gangliosides GT1b and GD1a.
Consistent with this idea VCN further alleviated the inhibitory
effect of MAG, but failed to annul it. These data not only suggest
that MAG uses independent pathways to signal growth inhibition,
but in addition support the existence of as yet unidentified
functional receptors on sensory neurons which are independent
from NgRs and terminal sialic acids. Precisely which additional
receptor components may play a role for MAG inhibition remains
to be elucidated. Although the neurotrophin receptor p75
NTR has
been reported to be involved in inhibitory MAG signaling
[14,15,20,38], the mechanism seems to be an indirect one,
possibly by forming a receptor complex with NgR1, because MAG
does not physically interact with p75
NTR [38].
Interestingly, further in vitro studies on the role of p75
NTR in
MAG inhibition pointed to cell-type specific differences in the
molecular machinery of MAG signaling. While DRG derived
sensory neurons deficient for p75
NTR are partially released from
MAG inhibition, no disinhibition could be observed for CGNs
lacking p75
NTR [20]. Such cell-type specificities are supported by a
recent study using pharmacological agents to determine the roles of
different neuronal MAG receptors [24]. These findings prompted
us to investigate whether cell-type specific variations in MAG
signaling on the receptor side are reflected at the ligand level. MAG
as ligand has been well characterized with regard to inhibition of
CGN. Although MAG, as lectin, binds with high specificity to a2,3-
linked sialic acid residues, this feature does not seem to play a role
for conferring inhibitory activity as demonstrated with a MAG
mutant,MAGR118A,that haslost itsaffinitytosialicacid butisstill
inhibitory to CGN [3].Furthermore, the inhibitory region on MAG
was mapped to the Ig-like domain 5 using CGN as responsive
neurons. Replacing the Ig-like domain 5 of sialoadhesin, like MAG
a member of the siglec family, with the Ig-like domain 5 of MAG
was shown to be necessary and sufficient to convert non-inhibitory
sialoadhesin into an inhibitory molecule with similar potency as
wildtype MAG [34]. To characterize MAG as ligand for sensory
neurons, we tested MAG R118 for its inhibitory potential. We did
not see disinhibition with MAG R118A indicating that sialic acid
binding of MAG is not necessary for inhibiting sensory neurons,
thus confirming data obtained with CGN. However, we did find a
significant difference to CGN inhibition with regard to the
inhibition site of MAG. In contrast to results obtained with CGN
[34], we localized the inhibitory region of MAG, using sensory
neurons and two types of chimeric proteins, over both Ig-like
domains 4 and 5. These data clearly indicate that the growth
inhibitory site on MAGis defined via the neuronal cell-type MAGis
interacting with. Furthermore, these results illustrate that variations
on the MAG receptor side might indeed go along with cognate
variations on the ligand side. It will be interesting to learn about
structural details of these apparently flexible ligand-receptor
interactions.
In sum, our findings support a model of MAG inhibition that is
cell-type specific and relies on at least three distinct, but partially
redundant, signaling modes. In sensory neurons, NgR1 and NgR2
account only to a minor extent for inhibitory signaling; sialylated
components, presumably including the gangliosides GT1b and
GD1a, as well as presently unknown factors which exert their
inhibitory activity independently from sialylation account for the
major effect or can effectively compensate for the loss of the NgR-
type MAG receptors. On the other hand, preventing MAG from
binding to sialic acid (and thus to gangliosides) or disrupting
gangliosides with VCN does not interfere with MAG’s inhibitory
activity, presumably because NgRs and presently unknown
sialylation independent factors can functionally compensate.
NgR1 has in fact been demonstrated to mediate MAG inhibition
in a VCN-insensitive manner [11,12]; the same holds true for
NgR2, although its preferred way seems to depend on sialic acid
binding of MAG [13]. The latter observation is significant because
it raises the possibility that the NgR and ganglioside pathways,
while distinct with regard to MAG binding, are not necessarily
independent from each other. Gangliosides are small lipid
molecules which are not likely to transduce signals by their own,
but rather depend on specific carrier proteins. NgR1, intriguingly,
has recently been identified as GT1b binding protein [39]. As
further shown, the GT1b-binding site is spatially distinct from the
MAG interaction site [39,40]. It is thus tempting to speculate that
NgR1 forms a dual MAG receptor complex with two distinct
binding sites for MAG; an indirect and VCN-sensitive one via the
GT1b-binding site and a direct and VCN-insensitive one via its
MAG interaction site.
Our data presented herein will help integrate knowledge on the
intricacies of MAG inhibition. Detailed information on the
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strategies to promote regeneration in the lesioned central and
peripheral nervous system.
Note
While this work was under review, Tessier-Lavigne and
colleagues published results showing that PirB, an Ig-like domain
containing transmembrane protein, is a functional MAG receptor
transducing inhibitory activity in CGN and DRG neurons [41], a
finding that is in perfect line with our data presented herein.
Supporting Information
Figure S1 Activity of VCN on cultured sensory neurons. In
order to address the specificity and effectiveness of VCN in our
neuronal culture, we treated sensory neurons after plating with
5 mU/ml of VCN and (A) lysed the cells after approx. 20 hours.
Immunoblotting of p75NTR, of which there are no reports about
sialylation, demonstrates the absence of proteolytic side-effects of
VCN. (B) Removal of sialic acid by VCN treatment increases
binding of cholera toxin (CT) to mono-sialoganglioside GM1 as
revealed by immunocytochemistry. The staining intensity of
p75NTR is not affected by VCN treatment. Scale bar 40 mm.
Found at: doi:10.1371/journal.pone.0005218.s001 (0.64 MB TIF)
Figure S2 Glycosylation of wildtype MAG and MAG mutants.
Wildtype and mutant MAG molecules which were expressed in
CHO-K1 clonal lines are differentially glycosylated; importantly,
the fully glycosylated form which, in wildtype MAG, migrates at
approx. 100 kD, is present in the wildtype and in all mutants
(arrow). Treatment of lysates with N-glycosidase F gives rise to an
approx. 72 kD immunoreactive band (asterisk) which corresponds
to the molecular weight of MAG core protein plus some O-linked
sugars [1]. MAG Ig1–3 is of lower molecular weight than the other
mutants but is shifted proportionally upon N-glycosidase treat-
ment. Anti-MAG antibody was used to detect wildtype and
mutant MAG molecules.
Found at: doi:10.1371/journal.pone.0005218.s002 (0.08 MB TIF)
Method S1
Found at: doi:10.1371/journal.pone.0005218.s003 (0.03 MB
DOC)
Method S2
Found at: doi:10.1371/journal.pone.0005218.s004 (0.02 MB
DOC)
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